CACNA1A | Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | ![](/images/64258/1331_H7_1_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/64258/144292_A_4_3_rna_selected_60x60.jpg) | Tissue enhanced |
CACNA1B | Calcium channel, voltage-dependent, N type, alpha 1B subunit | FDA approved drug targets Plasma proteins Predicted membrane proteins Voltage-gated ion channels
| ![](/images/44347/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/44347/97165_B_7_3_rna_selected_60x60.jpg) | Group enriched |
CACNA1C | Calcium channel, voltage-dependent, L type, alpha 1C subunit | Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/39796/84042_B_8_3_rna_selected_60x60.jpg) | Tissue enhanced |
CACNA1D | Calcium channel, voltage-dependent, L type, alpha 1D subunit | Cancer-related genes Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Voltage-gated ion channels
| ![](/images/20215/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/20215/47849_B_7_3_rna_selected_60x60.jpg) | Tissue enhanced |
CACNA1E | Calcium channel, voltage-dependent, R type, alpha 1E subunit | Predicted membrane proteins Voltage-gated ion channels
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |
CACNA1F | Calcium channel, voltage-dependent, L type, alpha 1F subunit | Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Mixed |
CACNA1G | Calcium channel, voltage-dependent, T type, alpha 1G subunit | FDA approved drug targets Plasma proteins Predicted membrane proteins Voltage-gated ion channels
| ![](/images/4714/ihc_selected_60x60.jpg) | ![](/images/4714/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/4714/13325_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
CACNA1H | Calcium channel, voltage-dependent, T type, alpha 1H subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images/39125/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/39125/91318_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
CACNA1I | Calcium channel, voltage-dependent, T type, alpha 1I subunit | FDA approved drug targets Plasma proteins Predicted membrane proteins Voltage-gated ion channels
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
CACNA1S | Calcium channel, voltage-dependent, L type, alpha 1S subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| | ![](/images_static/na_center.gif) | ![](/images/56815/ihc_cell_selected_60x60.jpg) | ![](/images/48892/130229_B_8_2_rna_selected_60x60.jpg) | Tissue enriched |
CATSPER2 | Cation channel, sperm associated 2 | Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Voltage-gated ion channels
| ![](/images/42709/ihc_selected_60x60.jpg) | ![](/images/42709/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/42709/93692_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
CATSPER4 | Cation channel, sperm associated 4 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | ![](/images_static/na_center.gif) | ![](/images/45257/158037_A_1_8_selected_60x60.jpg) | ![](/images/45257/142022_A_1_6_rna_selected_60x60.jpg) | Tissue enriched |
CNGA1 | Cyclic nucleotide gated channel alpha 1 | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images_static/rna_center.gif) | ![](/images/59734/1011_A10_1_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Mixed |
CNGA2 | Cyclic nucleotide gated channel alpha 2 | Predicted membrane proteins Voltage-gated ion channels
| ![](/images/15065/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/15065/35244_B_8_2_rna_selected_60x60.jpg) | Not detected |
CNGA3 | Cyclic nucleotide gated channel alpha 3 | Disease related genes Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Mixed |
CNGA4 | Cyclic nucleotide gated channel alpha 4 | Predicted intracellular proteins Predicted membrane proteins Voltage-gated ion channels
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
CNGB3 | Cyclic nucleotide gated channel beta 3 | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Voltage-gated ion channels
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
GALNT8 | Polypeptide N-acetylgalactosaminyltransferase 8 | Enzymes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Voltage-gated ion channels
| ![](/images/12638/ihc_selected_60x60.jpg) | ![](/images/12638/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/12638/29733_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
HCN1 | Hyperpolarization activated cyclic nucleotide-gated potassium channel 1 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Voltage-gated ion channels
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/19195/108171_B_8_6_rna_selected_60x60.jpg) | Tissue enriched |
HCN2 | Hyperpolarization activated cyclic nucleotide-gated potassium channel 2 | Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
HCN3 | Hyperpolarization activated cyclic nucleotide-gated potassium channel 3 | Plasma proteins Predicted membrane proteins Voltage-gated ion channels
| ![](/images/26584/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/26584/56137_B_8_1_rna_selected_60x60.jpg) | Mixed |
HCN4 | Hyperpolarization activated cyclic nucleotide-gated potassium channel 4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
KCNA1 | Potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia) | Disease related genes FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| ![](/images/22365/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/22365/48693_B_8_6_rna_selected_60x60.jpg) | Tissue enriched |
KCNA10 | Potassium voltage-gated channel, shaker-related subfamily, member 10 | FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| ![](/images/15061/ihc_selected_60x60.jpg) | ![](/images/22564/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/15061/34147_B_7_3_rna_selected_60x60.jpg) | Not detected |
KCNA2 | Potassium voltage-gated channel, shaker-related subfamily, member 2 | FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images/1976/5304_B_7_7_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/1976/5303_B_8_7_rna_selected_60x60.jpg) | Group enriched |
KCNA3 | Potassium voltage-gated channel, shaker-related subfamily, member 3 | FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images/16625/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/16625/39154_A_6_6_rna_selected_60x60.jpg) | Mixed |
KCNA4 | Potassium voltage-gated channel, shaker-related subfamily, member 4 | FDA approved drug targets Plasma proteins Predicted membrane proteins Voltage-gated ion channels
| ![](/images/16422/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/16422/41206_B_7_2_rna_selected_60x60.jpg) | Tissue enhanced |
KCNA5 | Potassium voltage-gated channel, shaker-related subfamily, member 5 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/21516/109609_B_7_2_rna_selected_60x60.jpg) | Group enriched |
KCNA6 | Potassium voltage-gated channel, shaker-related subfamily, member 6 | FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| ![](/images/14418/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/14418/34104_B_7_3_rna_selected_60x60.jpg) | Not detected |
KCNA7 | Potassium voltage-gated channel, shaker-related subfamily, member 7 | FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |
KCNB1 | Potassium voltage-gated channel, Shab-related subfamily, member 1 | FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | ![](/images_static/na_center.gif) | ![](/images/42434/134744_A_1_8_selected_60x60.jpg) | ![](/images/42434/134323_B_1_7_rna_selected_60x60.jpg) | Tissue enhanced |
KCNB2 | Potassium voltage-gated channel, Shab-related subfamily, member 2 | FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
KCNC1 | Potassium voltage-gated channel, Shaw-related subfamily, member 1 | FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| | ![](/images_static/na_center.gif) | ![](/images/47634/ihc_cell_selected_60x60.jpg) | ![](/images/47634/111871_B_8_5_rna_selected_60x60.jpg) | Tissue enriched |
KCNC2 | Potassium voltage-gated channel, Shaw-related subfamily, member 2 | FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| ![](/images/19664/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/19664/45838_B_9_2_rna_selected_60x60.jpg) | Tissue enriched |
KCNC3 | Potassium voltage-gated channel, Shaw-related subfamily, member 3 | Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images/18041/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/18041/40716_A_3_8_rna_selected_60x60.jpg) | Mixed |
KCNC4 | Potassium voltage-gated channel, Shaw-related subfamily, member 4 | Predicted membrane proteins Voltage-gated ion channels
| ![](/images/14740/ihc_selected_60x60.jpg) | ![](/images/14740/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/14740/35720_B_7_8_rna_selected_60x60.jpg) | Mixed |
KCND1 | Potassium voltage-gated channel, Shal-related subfamily, member 1 | FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Voltage-gated ion channels
| ![](/images/1066/ihc_selected_60x60.jpg) | ![](/images/524/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/1066/2346_B_7_6_rna_selected_60x60.jpg) | Mixed |
KCND2 | Potassium voltage-gated channel, Shal-related subfamily, member 2 | FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images/29068/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/29068/64679_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
KCND3 | Potassium voltage-gated channel, Shal-related subfamily, member 3 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images/29452/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/29452/63952_B_2_5_rna_selected_60x60.jpg) | Mixed |
KCNF1 | Potassium voltage-gated channel, subfamily F, member 1 | Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | ![](/images/14738/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/4678/18243_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
KCNG1 | Potassium voltage-gated channel, subfamily G, member 1 | Predicted intracellular proteins Predicted membrane proteins Voltage-gated ion channels
| ![](/images/40024/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/40024/93063_B_8_4_rna_selected_60x60.jpg) | Tissue enhanced |
KCNG2 | Potassium voltage-gated channel, subfamily G, member 2 | Predicted membrane proteins Voltage-gated ion channels
| ![](/images/48628/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/48628/111409_B_8_4_rna_selected_60x60.jpg) | Not detected |
KCNG3 | Potassium voltage-gated channel, subfamily G, member 3 | Predicted membrane proteins Voltage-gated ion channels
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
KCNG4 | Potassium voltage-gated channel, subfamily G, member 4 | Predicted membrane proteins Voltage-gated ion channels
| ![](/images/39161/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/39161/85084_B_9_1_rna_selected_60x60.jpg) | Not detected |
KCNH1 | Potassium voltage-gated channel, subfamily H (eag-related), member 1 | Predicted membrane proteins Voltage-gated ion channels
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/19445/151973_B_7_1_rna_selected_60x60.jpg) | Tissue enriched |
KCNH2 | Potassium voltage-gated channel, subfamily H (eag-related), member 2 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images/40783/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/40783/91893_B_7_7_rna_selected_60x60.jpg) | Tissue enhanced |
KCNH3 | Potassium voltage-gated channel, subfamily H (eag-related), member 3 | Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images/51088/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/51088/114510_B_8_4_rna_selected_60x60.jpg) | Group enriched |
KCNH4 | Potassium voltage-gated channel, subfamily H (eag-related), member 4 | Predicted membrane proteins Voltage-gated ion channels
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
KCNH5 | Potassium voltage-gated channel, subfamily H (eag-related), member 5 | Predicted membrane proteins Voltage-gated ion channels
| ![](/images/30487/ihc_selected_60x60.jpg) | ![](/images/30487/1046_E11_3_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/30487/66649_A_1_2_rna_selected_60x60.jpg) | Tissue enhanced |
KCNH6 | Potassium voltage-gated channel, subfamily H (eag-related), member 6 | Predicted membrane proteins Voltage-gated ion channels
| ![](/images/22674/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/22674/50804_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |